The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

Pharma’s sharply declining COVID-19 market is now grappling with a controversial new policy shift. Last week, HHS Secretary ...

In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

Press release Launch of a capital increase with preferential subscription rights for nearly 5 million euros Issuance of new shares for an initial total amount of around €5.0 million, with shareholders ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

The Global Single-use Assemblies Market valued at $2.25 billion (2021) is set to witness a healthy growth rate of 22% by 2026. Key advantages of ready-to-use single-use assemblies, favorable funding ...

The Global Sepsis Diagnostics Market valued at ~$510 million (2021) is set to witness a healthy growth rate of 9% in the next 5 years. Development of rapid diagnostic tests/point-of-care techniques, ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.